User:Andrew Su/UGCG

From Wikipedia, the free encyclopedia
Jump to: navigation, search
UDP-glucose ceramide glucosyltransferase
Identifiers
Symbols UGCG ; GCS; GLCT1
External IDs OMIM602874 MGI1332243 HomoloGene37763 IUPHAR: 2528 ChEMBL: 2063 GeneCards: UGCG Gene
EC number 2.4.1.80
RNA expression pattern
PBB GE UGCG 204881 s at tn.png
PBB GE UGCG 221765 at tn.png
More reference expression data
Orthologs
Species Human Mouse
Entrez 7357 22234
Ensembl ENSG00000148154 ENSMUSG00000028381
UniProt Q16739 O88693
RefSeq (mRNA) NM_003358 NM_011673
RefSeq (protein) NP_003349 NP_035803
Location (UCSC) Chr 9:
111.9 – 111.94 Mb
Chr 4:
59.19 – 59.22 Mb
PubMed search [1] [2]

UDP-glucose ceramide glucosyltransferase, also known as UGCG, is a human gene.[1]

Glycosphingolipids (GSLs) are a group of membrane components that contain lipid and sugar moieties. They are present in essentially all animal cells and are believed to have important roles in various cellular processes. UDP-glucose ceramide glucosyltransferase catalyzes the first glycosylation step in glycosphingolipid biosynthesis. The product, glucosylceramide, is the core structure of more than 300 GSLs. UGCG is widely expressed and transcription is upregulated during keratinocyte differentiation.[1]

Interactions[edit]

UGCG has been shown to interact with RTN1 [2].

References[edit]

  1. ^ a b "Entrez Gene: UGCG UDP-glucose ceramide glucosyltransferase". 
  2. ^ Di Sano, Federica (2003). "Glucosylceramide synthase and its functional interaction with RTN-1C regulate chemotherapeutic-induced apoptosis in neuroepithelioma cells". Cancer Res. United States. 63 (14): 3860–5. ISSN 0008-5472. PMID 12873973.  Unknown parameter |month= ignored (help); Unknown parameter |quotes= ignored (help); Unknown parameter |coauthors= ignored (|author= suggested) (help); Check date values in: |date= (help)

Further reading[edit]

  • Kohyama-Koganaya A, Hirabayashi Y (2002). "[Role of glucosylceramide synthase as negative regulator for ceramide]". Tanpakushitsu Kakusan Koso. 47 (4 Suppl): 470–5. PMID 11915344. 
  • Matsuo N, Nomura T, Imokawa G (1992). "A rapid and simple assay method for UDP-glucose:ceramide glucosyltransferase.". Biochim. Biophys. Acta. 1116 (2): 97–103. PMID 1533793. 
  • Ichikawa S, Sakiyama H, Suzuki G; et al. (1996). "Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis.". Proc. Natl. Acad. Sci. U.S.A. 93 (10): 4638–43. PMID 8643456. doi:10.1073/pnas.93.10.4638. 
  • Ichikawa S, Sakiyama H, Suzuki G; et al. (1996). "Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis.". Proc. Natl. Acad. Sci. U.S.A. 93 (22): 12654. PMID 8901638. doi:10.1073/pnas.93.10.4638. 
  • Watanabe R, Wu K, Paul P; et al. (1998). "Up-regulation of glucosylceramide synthase expression and activity during human keratinocyte differentiation.". J. Biol. Chem. 273 (16): 9651–5. PMID 9545298. doi:10.1074/jbc.273.16.9651. 
  • Ichikawa S, Ozawa K, Hirabayashi Y (1998). "Assignment of a UDP-glucose:ceramide glucosyltransferase gene (UGCG) to human chromosome band 9q31 by in situ hybridization.". Cytogenet. Cell Genet. 79 (3-4): 233–4. PMID 9605861. doi:10.1159/000134731. 
  • Tepper AD, Diks SH, van Blitterswijk WJ, Borst J (2000). "Glucosylceramide synthase does not attenuate the ceramide pool accumulating during apoptosis induced by CD95 or anti-cancer regimens.". J. Biol. Chem. 275 (44): 34810–7. PMID 10945987. doi:10.1074/jbc.M005142200. 
  • Ogretmen B, Schady D, Usta J; et al. (2001). "Role of ceramide in mediating the inhibition of telomerase activity in A549 human lung adenocarcinoma cells.". J. Biol. Chem. 276 (27): 24901–10. PMID 11335714. doi:10.1074/jbc.M100314200. 
  • Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. PMID 12477932. doi:10.1073/pnas.242603899. 
  • Di Sano F, Fazi B, Citro G; et al. (2003). "Glucosylceramide synthase and its functional interaction with RTN-1C regulate chemotherapeutic-induced apoptosis in neuroepithelioma cells.". Cancer Res. 63 (14): 3860–5. PMID 12873973. 
  • Grazide S, Terrisse AD, Lerouge S; et al. (2004). "Cytoprotective effect of glucosylceramide synthase inhibition against daunorubicin-induced apoptosis in human leukemic cell lines.". J. Biol. Chem. 279 (18): 18256–61. PMID 14766899. doi:10.1074/jbc.M314105200. 
  • Norris-Cervetto E, Callaghan R, Platt FM; et al. (2004). "Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells.". J. Biol. Chem. 279 (39): 40412–8. PMID 15263008. doi:10.1074/jbc.M404466200. 
  • Gerhard DS, Wagner L, Feingold EA; et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. PMID 15489334. doi:10.1101/gr.2596504. 
  • Turzanski J, Grundy M, Shang S; et al. (2005). "P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway.". Exp. Hematol. 33 (1): 62–72. PMID 15661399. doi:10.1016/j.exphem.2004.10.005. 
  • Sun NN, Fastje CD, Wong SS; et al. (2005). "Dose-dependent transcriptome changes by metal ores on a human acute lymphoblastic leukemia cell line.". Toxicology and industrial health. 19 (7-10): 157–63. PMID 15747776. doi:10.1191/0748233703th185oa. 
  • Rual JF, Venkatesan K, Hao T; et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network.". Nature. 437 (7062): 1173–8. PMID 16189514. doi:10.1038/nature04209. 
  • Fazi B, Melino S, Di Sano F; et al. (2006). "Cloning, expression, and preliminary structural characterization of RTN-1C.". Biochem. Biophys. Res. Commun. 342 (3): 881–6. PMID 16500619. doi:10.1016/j.bbrc.2006.02.036.